Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2025.
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Venmax Drugs & Pharmaceuticals Ltd. on 6ix
Earlier from Venmax Drugs & Pharmaceuticals
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Sep 29 2025
- Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Sep 27 2025
- Shareholder Meeting / Postal Ballot-Outcome of AGM
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Sep 26 2025
Later from Venmax Drugs & Pharmaceuticals
- Board Meeting Intimation for Unaudited Financial Results Of The Company For The Quarter Ended September 30, 2025.
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Nov 05 2025
- Board Meeting Outcome for Outcome Of The Board Meeting
- Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2025.
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Nov 12 2025
Follow Venmax Drugs & Pharmaceuticals into a list and get an email when it puts out news.
Follow Venmax Drugs & Pharmaceuticals